U.S. Stem Cell, Inc.【USRM】Cash flow
Market cap
$64.15K
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2020/12 | 2021/12 | 2022/12 | |
| Depreciation & amortization | 883,325 | 897,914 | 900,104 | 4,490 | 5,326 | 5,785 | 178,745 | 207,132 | - | - | - |
| Stock-based compensation | 10 | 10 | 10 | 537,606 | 1 | 410,002 | 645,483 | 1 | 701,939 | 556,556 | 384,380 |
| Cash from operations | -1,693,904 | -1,095,276 | -1,913,326 | -1,108,647 | -844,690 | 112,242 | 1 | 602,467 | -478,886 | -1,057,939 | -304,852 |
| Capital expenditures | -898,800 | -899,733 | -909,158 | -8,121 | -2,035 | -12,582 | -1,162 | - | - | - | - |
| Cash from investing | -898,800 | -933 | -9,425 | -57,835 | -234,031 | 155,101 | 723,838 | 311,700 | - | - | - |
| Repurchases of common stock | - | - | - | - | 221,996 | 7,817 | - | - | - | - | - |
| Cash from financing | 73 | 74 | 76 | 1 | 1 | -54,995 | -1,239,152 | -543,820 | 497,456 | 1 | 270,592 |
| Free cash flow | - | - | - | ||||||||
| FCF margin (%) | - | - | - |